BCR/ABL activates mdm2 mRNA translation via the La antigen (Q40666171)

22 September 2017

BCR/ABL activates mdm2 mRNA translation via the La antigen (English)

1 reference

22 September 2017

11

Michael A Caligiuri

1 reference

22 September 2017

Rossana Trotta

1

1 reference

22 September 2017

Tatiana Vignudelli

2

1 reference

22 September 2017

Olivia Candini

3

1 reference

22 September 2017

Robert V Intine

4

1 reference

22 September 2017

Luisa Pecorari

5

1 reference

22 September 2017

Clara Guerzoni

6

1 reference

22 September 2017

Giorgia Santilli

7

1 reference

22 September 2017

Mike W Byrom

8

1 reference

22 September 2017

Silvia Goldoni

9

1 reference

22 September 2017

Lance P Ford

10

1 reference

22 September 2017

Richard J Maraia

12

1 reference

22 September 2017

Danilo Perrotti

13

1 reference

22 September 2017

Bruno Calabretta

14

1 reference

22 September 2017

1 February 2003

1 reference

22 September 2017

1 reference

22 September 2017

3

1 reference

22 September 2017

145-160

1 reference

22 September 2017

2

1 reference

Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Detailed analysis of the phosphorylation of the human La (SS-B) autoantigen. (De)phosphorylation does not affect its subcellular distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Role of two upstream open reading frames in the translational control of oncogene mdm2.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

The La autoantigen contains a dimerization domain that is essential for enhancing translation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

5' processing of tRNA precursors can Be modulated by the human La antigen phosphoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

p53 in chronic myelogenous leukemia in acute phase

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Translational regulation of human p53 gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

The MDM2 RING-finger domain is required to promote p53 nuclear export

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Biological consequences of the BCR/ABL fusion gene in humans and mice

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Mdm2 promotes the rapid degradation of p53

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Ro Small Cytoplasmic Ribonucleoproteins Are a Subclass of La Ribonucleoproteins: Further Characterization of the Ro and La Small Ribonucleoproteins from Uninfected Mammalian Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Aberrant nuclear trafficking of La protein leads to disordered processing of associated precursor tRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Control of transfer RNA maturation by phosphorylation of the human La antigen on serine 366

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

La autoantigen enhances translation of BiP mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Regulation of p53 stability by Mdm2

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Regulation of p53 in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Protein kinase C: structure, function, and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Analysis of the p53 and MDM-2 gene in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Immunoprecipitation of ribonucleoproteins using autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Repression of p53-mediated transcription by MDM2: a dual mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

1 reference

7 January 2021

Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900020-5

7 January 2021

10.1016/S1535-6108(03)00020-5

Identifiers

DOI

1 reference

22 September 2017

1 reference